Edesa Biotech Inc.

NASDAQ: EDSA · Real-Time Price · USD
2.22
-0.04 (-1.77%)
At close: Aug 15, 2025, 2:57 PM

Edesa Biotech Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Net Income
-6.17M -8.37M -17.55M -13.34M
Depreciation & Amortization
186.05K 183.47K 118.19K 118.79K
Stock-Based Compensation
537.49K 1.25M 2.26M 3.2M
Other Working Capital
214.73K 301.5K -2.03B -281.36K
Other Non-Cash Items
-14.77K 308K 2.38M 3.31M
Deferred Income Tax
n/a -308K -2.38M -3.31M
Change in Working Capital
571.07K 308K 2.89M -3.64M
Operating Cash Flow
-4.89M -6.64M -12.28M -13.66M
Capital Expenditures
n/a 3.00 -5.66K -6.15K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a -5.66K -6.15K
Debt Repayment
-29.53K n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-107.82K 485.09K -328.06K 1.51M
Financial Cash Flow
592.03K 4.83M 11.63M 14.17M
Net Cash Flow
-4.32M -1.73M -748.34K 625.56K
Free Cash Flow
-4.89M -6.64M -12.28M -13.67M